Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...

Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics (Nasdaq: IPSC), a UK immunotherapy company ...

San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...

Switzerland-based MetP Pharma, pioneer in nose-to-brain drug delivery for nearly two decades, announced new data highlighting ...

Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the ...

The US subsidiary of South Korea-based Celltrion today announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) ...

US biotech Cogent Biosciences closed Monday’s trading 23% higher, following the company’s announcement of positive top-line ...

Having appointed Renée Aguiar-Lucander as its chief executive in April and Maria Törnsén as chief operating officer a month ...

US CAR-T focused biotech CARGO Therapeutics today announced that it has entered into a definitive merger agreement with ...

Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also ...

Shares of US clinical-stage biotech Apogee Therapeutics closed down 17.3% at $39.24 yesterday, despite announcing positive 16 ...

Otsuka subsidiary Taiho Pharmaceuticals earlier announced that the results of a Phase III, randomized, placebo-controlled, ...